483 Document: Hubei Granules Biocause Pharmaceutical Co. Ltd., Aug 16, 2019

FDANews 483 Hubei Granules Biocause Pharmaceutical Co. Ltd. Aug 16 2019 top
Jay T. Wong FDA Investigator

On Aug 16, 2019, the FDA inspected Hubei Granules Biocause Pharmaceutical Co. Ltd.'s Jingmen site. Explore the inspectional observations.